Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection

Clinical Infectious Diseases

Volumn 55, Issue 12, 2012, Pages 1652-1658

  Zipursky, Jonathan S ^a   Sidorsky, Tivon I ^b   Freedman, Carolyn A ^c   Sidorsky, Misha N ^d   Kirkland, Kathryn B ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d DARTMOUTH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENEMA; METRONIDAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOGASTRIC TUBE; PATIENT ATTITUDE; PERCEPTION; PRIORITY JOURNAL; RECURRENT INFECTION; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RECURRENCE; TRANSPLANTATION;

EID: 84870178314     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis809     Document Type: Article

References (23)

1. Kachrimanidou M, Malisiovas N. Clostridium difficile infection: A comprehensive review. Crit Rev Microbiol 2011; 37:178-87.
2. Bartlett JG. Narrative review: The new epidemic of Clostridium difficile-Associated enteric disease. Ann Intern Med 2006; 145:758-64.
3. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006; 12:409-15.
4. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med 2008; 359:1932-40.
5. Gravel D, Miller M, Simor A, et al. Health care-Associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: A Canadian Nosocomial Infection Surveillance Program study. Clin Infect Dis 2009; 48:568-76.
6. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-Associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005; 173:1037-42.
7. United Kingdom national statistics. Newport, United Kingdom: Office for National Statistics, UK Statistics Authority. Available at: Www. statistics.gov.uk. Accessed 26 September 2012.
8. Pepin J, Alary ME, Valiquette L, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005; 40:1591-7. (Pubitemid 40720808)
9. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010; 31:431-55.
10. Surawicz CM. Treatment of recurrent Clostridium difficile-Associated disease. Nat Clin Pract Gastroenterol Hepatol 2004; 1:32-8. (Pubitemid 40823691)
11. van Nood E, Speelman P, Kuijper EJ, Keller JJ. Struggling with recurrent Clostridium difficile infections: Is donor faeces the solution? Euro Surveill 2009; 14. pii:19316.
12. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009; 15:285-9.
13. Huebner ES, Surawicz CM. Treatment of recurrent Clostridium difficile diarrhea. Gastroenterology Hepatol 2006; 2:203-7.
14. Pepin J, Routhier S, Gagnon S, Brazeau I. Management and outcomes of a first recurrence of Clostridium difficile-Associated disease in Quebec, Canada. Clin Infect Dis 2006; 42:758-64.
15. Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: Toying with human motions. J Clin Gastroenterol 2004; 38:475-83.
16. Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44:854-9.
17. Borody TJ, Leis SM, Pang G, Wettstein AR. Fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection. Available at: Www.uptodate.com. Accessed 14 December 2010.
18. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53:994-1002.
19. Kahn SA, Gorawara-Bhat R, Rubin DT. Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we? Inflamm Bowel Dis 2012; 17:676-84.
20. Borody TJ, Campbell J. Fecal microbiota transplantation: Current status and future directions. Expert Rev Gastroenterol Hepatol 2011; 5:653-5.
21. Brandt LJ, Aroniadis OC, Mellow M, et al. Long-Term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107:1079-87.
22. Bakken JS, Borody T, Brandt LJ, et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 12:1044-9.
23. US Department of Education, National Center for Education Statistics. Digest of education statistics. 2011, Chapter 3. Available at: Http://nces.ed.gov/programs/digest/d11/ch-3.asp. Accessed 26 September 2012.